T1 Energy Inc (TE) Stock News

Rosen Law Firm has filed a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare billing, falsification of nursing assistant hours, and illegal licensing schemes. Investors who purchased during the class period may be entitled to compensation. The deadline to serve as lead plaintiff is December 7, 2026.

Rosen Law Firm is encouraging investors in York Space Systems Inc. (NYSE: YSS) to join a securities class action lawsuit with an October 30, 2026 deadline for lead plaintiff claims. The lawsuit alleges that York Space made materially false statements about its satellite software functionality, deceived the Pentagon's Space Development Agency with false advertising, and delivered satellites with incomplete mission-critical software, causing investor damages when the truth emerged.

Rosen Law Firm announces a securities class action lawsuit against Aardvark Therapeutics, Inc. for allegedly making materially false and misleading statements regarding the safety and prospects of its drug ARD-101. Investors who purchased securities during the IPO on February 13, 2025 or between February 13, 2025 and May 14, 2026 may be eligible to join the class action. The deadline to serve as lead plaintiff is October 13, 2026.

Rosen Law Firm is encouraging investors who purchased FuelCell Energy (FCEL) securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false and misleading statements regarding its manufacturing capacity, production rates under a capital equipment purchase agreement with Fit Energy, and profitability. The lead plaintiff deadline is November 10, 2026.

Rosen Law Firm has filed securities class action lawsuits against Qfin Holdings, FuelCell Energy, and Fluence Energy on behalf of investors who purchased securities during specified periods. The lawsuits allege that defendants made false or misleading statements regarding business resilience, financial results, and the impact of regulatory changes. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.

Rosen Law Firm has filed securities class action lawsuits against Flotek Industries, FuelCell Energy, and Fluence Energy. The Flotek lawsuit alleges defendants made false statements regarding a Puerto Rico Electric Power Authority contract, claiming there were credible reasons to doubt the consortium's capacity to deliver promised revenues. Investors who purchased securities during specified class periods are encouraged to secure counsel before upcoming lead plaintiff deadlines.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Innventure, Inc., where defendants allegedly made false statements about Accelsius Holdings' transformative deal with DarkNX and overstated revenue targets. The lead plaintiff deadline is October 27, 2026. Similar lawsuits are also being pursued against AST SpaceMobile, Inc. and GoDaddy Inc.

SINTX Technologies received a Zacks Rank #2 (Buy) upgrade driven by upward trends in earnings estimates. The company's consensus estimate for fiscal year 2026 has increased 26.4% over the past three months, positioning it in the top 20% of Zacks-covered stocks and suggesting potential near-term stock price appreciation.

NEWSLETTER: The war's explosive new front  Reuters

Advantest Corp. (ATEYY) is highlighted as a strong momentum pick with a Zacks Rank #1 (Strong Buy) rating and Momentum Style Score of A. The stock has significantly outperformed its industry and the broader market, gaining 16.34% over the past week, 44.46% over the past quarter, and 127.23% over the past year. Earnings estimates have also been revised upward, with the consensus estimate increasing from $4.95 to $6.48 in the past 60 days.

Dimensional Fund Advisors Ltd. has disclosed a 1.59% interest in Tate & Lyle PLC, comprising 7,093,049 ordinary shares as of October 6, 2026. The disclosure includes a sale of 139,076 shares at 5.6034 GBP per unit and a transfer in of 1,956 shares. Dimensional expressly disclaims beneficial ownership and notes it lacks discretion over 61,621 of the shares disclosed.

21shares announced a 12-month extension of the 100% sponsor fee waiver for its Ethereum Staking ETF (TETH) through October 2027, allowing investors zero-cost exposure to Ethereum staking with a current net staking reward of 2.65%. The extension applies automatically to all shareholders and underscores the company's commitment to providing cost-efficient cryptocurrency access.

Innovayte, a custody and clearing firm for registered investment advisors, announced the appointment of Fritz Louis-Charles as Chief Operating Officer. Louis-Charles brings over 20 years of financial services experience, including previous roles as COO of Apex Fintech Solutions and leadership positions at JPMorgan Chase and TD Ameritrade. He will oversee enterprise-wide operations and help guide the firm's next growth phase.

Rosen Law Firm reminds investors who purchased Flotek Industries (FTK) securities between August 3-17, 2026 of the October 26, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges defendants made false statements about a Puerto Rico Electric Power Authority contract, failing to disclose credibility concerns about consortium parties and risks to revenue realization.

YSX Tech (NASDAQ: YSXT), a Cayman Islands company providing business solutions for Chinese insurance companies, announced an extraordinary general meeting scheduled for October 19, 2026. The meeting will vote on three proposals: increasing authorized share capital from US$50,000 to US$220,000 million, reducing notice period for general meetings from 7-14 days to 5 days, and adopting amended articles of association.

Rosen Law Firm has filed class action lawsuits against Celsius Holdings, Inc. and other companies on behalf of investors who purchased securities during specified periods. The Celsius lawsuit alleges that the company made materially false and misleading statements regarding cardiac risks associated with Alani Nu products and inappropriately marketed these products to consumers under 18. Investors who purchased Celsius securities between February 21, 2025 and June 3, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is November 3, 2026.

Teradyne stock declined 1% on October 5, 2026, underperforming the broader market gains. Despite the daily decline, TER has appreciated 25.77% over the past month. The company is expected to report strong earnings growth of 140% YoY with revenue rising 65.2%, though the stock trades at a premium valuation with a Forward P/E of 49.31 compared to its industry average of 20.65. Teradyne currently holds a Zacks Rank of #3 (Hold).

TELA Bio announced FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable surgical mesh device for soft tissue reinforcement. Liora is the first fully resorbable synthetic product in the company's portfolio to be designed and produced in-house at its ISO 8 certified cleanroom in Malvern, PA, expanding TELA Bio's soft tissue reconstruction market footprint.

YieldMax® announced weekly distributions for three Performance & Distribution Target 25 ETFs tracking MSTR, NVDA, and TSLA, with distribution rates of 25.00% and 30-day SEC yields ranging from 0.41% to 3.11%. The distributions are ex-dated October 6, 2026 and payable October 7, 2026. The article emphasizes that distributions are variable and not guaranteed, with significant risks including call writing strategy limitations and single-issuer concentration.

Vallourec announces the appointment of Isabelle Quéméneur as Group Chief Digital and Information Officer, effective October 5, 2026. Quéméneur, previously Chief Technology Officer at Danone, joins Vallourec's Executive Committee to lead digital transformation initiatives focused on customer value creation and modernizing team operations in response to cybersecurity and AI challenges.

Vallourec announces the appointment of Isabelle Quéméneur as Director of Digital & IT Systems, effective October 5, 2026. She joins the Executive Committee and brings extensive experience from her previous role as CTO at Danone, along with a background in technology leadership at major international companies including Société Générale, AXA, and Sanofi.

Rosen Law Firm is notifying investors of upcoming lead plaintiff deadlines in securities class action lawsuits against Flotek Industries, The Simply Good Foods Company, and Dun & Bradstreet Holdings. The lawsuits allege materially false and misleading statements regarding business operations and financial prospects.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Flotek Industries (FTK), where investors who purchased securities between August 3-17, 2026 may be entitled to compensation. The lawsuit alleges that Flotek made materially false statements regarding a Puerto Rico Electric Power Authority contract, failing to disclose credible doubts about the consortium's capacity to deliver on the project. The lead plaintiff deadline is October 26, 2026.

A securities class action lawsuit has been filed against ARS Pharmaceuticals for allegedly providing false and misleading statements regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company allegedly stated coverage would begin July 1, 2026, while concealing material adverse facts about the actual timeline, causing investors to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

Rosen Law Firm is reminding investors who purchased Ardelyx common stock between January 13, 2025 and August 6, 2026 of an important November 16, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Ardelyx provided misleading statements about its commercial performance and concealed material facts regarding reimbursement barriers and access issues for its drugs XPHOZAH and IBSRELA.

Rosen Law Firm has announced multiple securities class action lawsuits against Aardvark Therapeutics, FuelCell Energy, and XTI Aerospace. The primary case involves Aardvark Therapeutics, where investors claim the company made materially false statements about the safety and prospects of its ARD-101 drug candidate in its IPO registration statement and throughout the class period. Investors have until October 13, 2026 to become lead plaintiffs in the Aardvark case.

Dimensional Fund Advisors Ltd. has disclosed a 1.65% interest in Tate & Lyle PLC, comprising 7,360,601 ordinary shares as of October 1, 2026. The disclosure includes a sale of 30,929 shares at 5.5877 GBP per unit and a transfer in of 34,778 shares. Dimensional, acting as an investment advisor, expressly disclaims beneficial ownership of the shares.

SCTE wrapped up TechExpo26 in Atlanta, attracting over 245 speakers, 300 exhibitors, and thousands of industry leaders from 50+ countries. The event highlighted the shift toward intelligent, converged broadband networks powered by AI and automation. Key discussions included cybersecurity infrastructure protection with White House National Cyber Director Sean Cairncross, and the STRIKE initiative to combat broadband infrastructure theft and attacks. TechExpo27 is planned for Denver in September 2027.

Trio Petroleum Corp acquired 24 oil wells (4 producing, 20 shut-in) from Marlin Resources Ltd in Saskatchewan's Lloydminster region for CDN$800,000 cash plus an underutilized water disposal asset. The acquisition includes 37 BOPD of current production, a planned Cummings multilateral well with CDN$1.2 million development budget, and a CDN$425,000 workover program. The company expects the purchase price per flowing barrel to be discounted compared to market rates for comparable assets.

Lumentum Holdings (LITE) and Navitas Semiconductor (NVTS) are two key players benefiting from AI data center demand. Lumentum is experiencing surging demand for optical components with 109% YoY revenue growth and strong earnings momentum, while Navitas faces ongoing losses and execution risks despite ramping AI power programs. Lumentum is rated as the stronger investment opportunity with a Zacks Rank #2 (Buy) versus Navitas's Rank #3 (Hold).